1. Generics Bulletin
  2. >>Policy & Regulation
  3. >>Regulation

EMA Urges Suspension Of European Generics Tested By Synapse

As CHMP Also Issues Positive Opinions For Four New Generics In December

 
• By Dave Wallace

At the latest CHMP meeting, the EMA revealed that it was recommending the suspension of marketing authorizations for more than 400 medicines tested by Indian CRO Synapse Labs. At the same time, the committee separately endorsed four new generics.

EMA
The EMA has recommended suspending MAs linked to Synapse

More than 400 medicines tested by Synapse Labs Pvt should have their European marketing authorizations suspended, the European Medicines Agency has recommended, following the discovery of data and documentation issues at the Indian contract research organization.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation